On Friday, 10x Genomics Inc (NASDAQ: TXG) was -5.52% drop from the session before settling in for the closing price of $14.12. A 52-week range for TXG has been $14.02 – $57.90.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 35.76%. When this article was written, the company’s average yearly earnings per share was at 35.26%. With a float of $99.73 million, this company’s outstanding shares have now reached $105.04 million.
The extent of productivity of a business whose workforce counts for 1259 workers is very important to gauge. In terms of profitability, gross margin is 65.89%, operating margin of -28.3%, and the pretax margin is -27.93%.
10x Genomics Inc (TXG) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward 10x Genomics Inc stocks. The insider ownership of 10x Genomics Inc is 17.25%, while institutional ownership is 78.84%. The most recent insider transaction that took place on Aug 22 ’24, was worth 152,053. In this transaction Chief Executive Officer of this company sold 6,749 shares at a rate of $22.53, taking the stock ownership to the 882,467 shares. Before that another transaction happened on Aug 22 ’24, when Company’s See Remarks sold 4,351 for $22.53, making the entire transaction worth $98,027. This insider now owns 345,704 shares in total.
10x Genomics Inc (TXG) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted 0.08 earnings per share (EPS) during the time that was better than consensus figure (set at -0.02) by 0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 35.26% per share during the next fiscal year.
10x Genomics Inc (NASDAQ: TXG) Trading Performance Indicators
You can see what 10x Genomics Inc (TXG) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.42. Likewise, its price to free cash flow for the trailing twelve months is 58.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.53, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.23 in one year’s time.
Technical Analysis of 10x Genomics Inc (TXG)
The latest stats from [10x Genomics Inc, TXG] show that its last 5-days average volume of 2.5 million was superior to 1.73 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 1.16%. Additionally, its Average True Range was 1.04.
During the past 100 days, 10x Genomics Inc’s (TXG) raw stochastic average was set at 0.39%, which indicates a significant decrease from 0.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 52.44% in the past 14 days, which was lower than the 86.46% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.42, while its 200-day Moving Average is $26.03. Now, the first resistance to watch is $13.84. This is followed by the second major resistance level at $14.34. The third major resistance level sits at $14.62. If the price goes on to break the first support level at $13.07, it is likely to go to the next support level at $12.79. The third support level lies at $12.29 if the price breaches the second support level.
10x Genomics Inc (NASDAQ: TXG) Key Stats
There are 121,054K outstanding shares of the company, which has a market capitalization of 1.53 billion. As of now, sales total 618,730 K while income totals -255,100 K. Its latest quarter income was 151,650 K while its last quarter net income were -35,750 K.
